CYLERT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cylert, and when can generic versions of Cylert launch?
Cylert is a drug marketed by Abbott and is included in two NDAs.
The generic ingredient in CYLERT is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
Summary for CYLERT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Patent Applications: | 5,192 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CYLERT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CYLERT
US Patents and Regulatory Information for CYLERT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | CYLERT | pemoline | TABLET, CHEWABLE;ORAL | 017703-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | CYLERT | pemoline | TABLET;ORAL | 016832-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | CYLERT | pemoline | TABLET;ORAL | 016832-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbott | CYLERT | pemoline | TABLET;ORAL | 016832-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |